{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
UCSF Office of CME Home
Client Logo
  • Sign In
  • Live Courses
  • On Demand
  • Grand Rounds
  • About Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

UCSF Employees and Affiliates – Please use your UCSF MyAccess Login to access the CE Portal. Use the button on the left.

All Others – Please use your email address and password associated with your account. Use the button on the right.

Once you have signed in, please ensure that your profile is complete to access the system’s full functionality.

Note: If you have logged into a UCSF CME system in the past, your account may already be active,
and you will need to set a new password. Do not create a duplicate account.

UCSF MyAccess Login
Login with an Email and Password or Create an Account
Enter your email and password to login:

*
*
Login

New to UCSF? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AHI
  • APBCC
  • APRN
  • AuD
  • AuD, PhD
  • BA
  • BCC
  • BS
  • BSN
  • BSRT
  • CAC
  • CCMA-C
  • CCT
  • CHES
  • CM
  • CNM
  • CPhT
  • CPM
  • CRNA
  • CRNP
  • CTR
  • CVT
  • DDS
  • DMD
  • DNP
  • DO
  • DO, MPH
  • DPM
  • DPT
  • EMT
  • EMT-P
  • FNP-BC
  • JD
  • LAc
  • LCSW
  • LNM
  • LPN
  • MA
  • MB BChir
  • MBBS
  • MD
  • MD, DDS
  • MD, JD
  • MD, MBA
  • MD, MPH
  • MD, MS
  • MD, PhD
  • MPH
  • MSN
  • MSPH
  • MSW
  • None
  • NP
  • OD
  • OT
  • Other
  • OTR
  • PA-C
  • PharmD
  • PhD
  • PsyD
  • PT
  • RCES
  • RCP
  • RD
  • RDMS
  • RN
  • RN, BSN
  • RPHt
  • RT
  • RTT
  • SLP
Degree is required
Please enter your degree:
You must enter a degree

Profession is required

User Agreement

The University of California, San Francisco (“UCSF”) knows that you care about how your information is used and shared. UCSF takes seriously the protection of your privacy. Please read below about how UCSF uses and protects information collected through our websites. By using the Office of Continuing Medical Education website and participating in UCSF’s continuing education (CE) program in any manner, you acknowledge that you accept the practices and policies outlined in this Website Privacy Policy.

See our full policy at https://www.ucsf.edu/website-privacy-policy.


You must agree to the terms and conditions before registering.




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

The Peter R. Carroll Innovation Summit: Good, Better, Best: Looking Forward and Reflecting on the Past

  • Overview
  • Faculty
Add to Calendar The Peter R. Carroll Innovation Summit: Good, Better, Best: Looking Forward and Reflecting on the Past 11/6/2026 8:00:00 AM 11/6/2026 3:00:00 PM America/Los_Angeles For More Details: https://ucsf.cloud-cme.com/course/courseoverview?EID=20347 Description: This event will bring together practicing urologists, residents, fellows, and researchers to share knowledge and advance evidence-based urologic care. The program is designed to enhance clinical expertise by presenting research findings, clinical care pathways, innovations, and other key advancements. The program will include presentations and interactive panel discussions related to clinical research... UCSF Genentech Hall false MM/DD/YYYY


Date & Location
Friday, November 6, 2026, 8:00 AM - 3:00 PM, UCSF Genentech Hall, San Francisco, CA

Target Audience
Specialties - Pediatric Urology, Urogynecology and Reconstructive Pelvic Surgery, Urology
Professions - Health Educator, Non-Physician, Nurse, Nurse Practitioner/Advanced Practice Nursing, Other Health Professional, Physician, Physician Assistant/Associate

Credits
AMA PRA Category 1 Credits™ (4.00 hours)

Overview
This event will bring together practicing urologists, residents, fellows, and researchers to share knowledge and advance evidence-based urologic care. The program is designed to enhance clinical expertise by presenting research findings, clinical care pathways, innovations, and other key advancements. The program will include presentations and interactive panel discussions related to clinical research, clinical practice, leadership development, and collaboration. These activities aim to support the development of practicing urologists in academics and community practice alike and inspire the next generation of trainees.

Objectives
As a result of the education, I intend to:

  1. Evaluate new and emerging clinical care pathways, clinical trial data, and guideline-based recommendations to inform evidence-based urology practice
  2. Interpret and integrate novel findings from health services, clinical, and translational research into clinical decision-making
  3. Apply advances in surgical and procedural techniques to improve patient outcomes and optimize care delivery
  4. Identify and implement strategies for leadership development and career advancement within academic and clinical urology settings

Accreditation

Jointly Accredited Provider with Commendation

In support of improving patient care, the University of California, San Francisco Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Additional Information

Cancellation Policy
Cancellations received in writing at least 30 days before the conference start date will receive a refund of registration fees minus a [10%] administrative fee. Requests received between 30 days and 14 days before the start date will receive a 50% refund. No refunds will be issued within 14 days of the start date. Please send cancellation requests through our Refund Request form.
 
UCSF Office of CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets, hotel penalties, or other related personal expenses.

Accessibility Statement
UCSF welcomes all participants to our events. If you need a reasonable accommodation to participate in this event because of a disability, please submit a learner support ticket as soon as possible.

UCSF Land Acknowledgment Statement
We would like to acknowledge the Ramaytush Ohlone people, who are the traditional custodians of this land. We pay our respects to the Ramaytush Ohlone elders, past, present, and future, who call this place, the land that UCSF sits upon, their home. We are proud to continue their tradition of coming together and growing as a community. We thank the Ramaytush Ohlone community for their stewardship and support, and we look forward to strengthening our ties as we continue our relationship of mutual respect and understanding.

For more information, visit https://opportunity.ucsf.edu/initiatives/ucsf-land-acknowledgment.

This UCSF continuing education activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

UCSF adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including content planners, reviewers, authors, presenters, moderators, panelists, or others are required to disclose all financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Mitigation of Relevant Financial Relationships

This UCSF continuing education activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

UCSF adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including content planners, reviewers, authors, presenters, moderators, panelists, or others are required to disclose all financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Michelle Lifto, BS
Administrative Officer II
UCSF
Activity Administrator
Non-Clinical Exception
Carissa Chu, MD
UCSF
Course Director, Faculty, Peer Reviewer
Non-Clinical Exception
Robert Blelloch, MD, PhD
Professor
UCSF
Faculty
Nothing to disclose
Peter Bruno, PhD
University of California, San Francisco
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sift Biosciences
Clint Cary, MD, MPH
Professor & Chair
Indiana University School of Medicine
Faculty
June Chan, ScD
Dr
UCSF
Faculty
Other: My husband is a full-time employee of this company.-Adela, Inc.|Other: Veracyte will run gene expression assessments (w/o charge) on ~ 40 patients' samples from one of our clinical trials, as part of prior research agreements that was part of an NIH grant award. -Veracyte
Meera Chappidi, MD, MPH
UCSF
Faculty
Nothing to disclose
Lisa Chesner, PhD
Assistant Adjunct Professor
UCSF
Faculty
Nothing to disclose
Thomas Chi, MD, MBA, FACS
Professor and Chair
University of Alabama at Birmingham
Faculty
Consulting Fee-Boston Scientific Corporation|Advisor-Auris|Advisor-Bard Peripheral Vascular, Inc.|Advisor-Dornier |Consulting Fee-Cook Medical, Inc.|Advisor-Lumenis|Advisor-Vibronix|Advisor-Mendaera|Advisor-UroViu|Consulting Fee-Calyxo|Advisor-Andromeda Surgical|Consulting Fee-Johnson & Johnson--Select--|Consulting Fee-Akeeko Medical|Consulting Fee-GE Healthcare
Matthew Cooperberg, MD
UCSF
Faculty
Advisor-Bayer (Any division)|Advisor-Johnson & Johnson|Advisor-Veracyte|Advisor-Merck (Any division)|Advisor-Pfizer (Any division)|Advisor-ArteraAI|Advisor-InSyte Bio|Advisor-Alessa|Advisor-MDxHealth|Advisor-ExosomeDx|Advisor-BlueEarth|Advisor-Tolmar
Janet Cowan, MA
UCATS Stats Manager
UCSF
Faculty
Nothing to disclose
Marc Dall'Era, MD, Professor and Chair
Dr.
UC Davis
Faculty
Nothing to disclose
Benjamin Davies, MD
Faculty
Claire de la Calle, MD
University of Washington
Faculty
Nothing to disclose
Chien-Kuang C Ding, MD, PhD
Assistant Professor
UCSF
Faculty
Advisor-Johnson & Johnson (Relationship has ended)|Grant or research support-Intuitive Surgical
Tracy Downs
Faculty
Kirsten Greene, MD
University of Virgina
Faculty
Stocks or stock options, excluding diversified mutual funds-INtuitvie
Christopher J. Kane, MD
Professor and Senior Assistant Vice Chancellor
UC San Diego
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca (Any division)
Barry Kogan, MD
Professor
Albany Medical College
Faculty
Nothing to disclose
Badrinath R Konety, MD
Faculty
Michael Leapman, MD
Dr.
Yale School of Medicine
Faculty
Nothing to disclose
Peter E Lonergan, MD
St. James's Hospital
Ireland
Faculty
Nothing to disclose
Viraj Master, MD, PhD, FACS
Emory University
Faculty
Nothing to disclose
Maxwell Meng, MD
UCSF
Faculty
Nothing to disclose
Hao Nguyen, MD, PhD, Professor
Professor in Reaidence
UCSF Helen Diller Comprehensive Cancer Center
Faculty
Nothing to disclose
Anobel Odisho, MD
UCSF
Faculty
Nothing to disclose
Sima Porten, MD
UCSF
Faculty
Advisor-Photocure|Consulting Fee-Stryker (Any division)|Honoraria-Natera|Honoraria-Astellas (Any division) (Relationship has ended)
Sanoj Punnen, MD
UNIVERSITY OF MIAMI
Faculty
Advisor-ExosomeDx (Relationship has ended)
David Quigley, PhD
Associate Professor
University of California San Francisco
Faculty
Nothing to disclose
Nadia Roan, PhD
UCSF
Faculty
Nothing to disclose
Davide Ruggero, PhD
University of California, San Francisco
Faculty
Nothing to disclose
Samuel L Washington, MD
Dr
University of California, San Francisco
Faculty
Nothing to disclose
Benjamin Breyer, MD
UCSF
Faculty, Other Planning Committee Member, Peer Reviewer
Nothing to disclose
Sian Mara, PA-C
UCSF
Other Planning Committee Member
Nothing to disclose

Friday, November 6, 2026

Breakfast
7:30AM - 8:00AM


7:55AM-8:00 AM Welcome by Dr. Benjamin Breyer and Dr. Carissa Chu
Building a Department and Shaping Health Systems
8:00AM - 9:00AM
Benjamin Breyer, MD (Moderator)
Christopher J. Kane, MD (Presenter)
Badrinath R Konety, MD (Presenter)
Kirsten Greene, MD (Presenter)
Marc Dall'Era, MD, Professor and Chair (Panelist)
Barry Kogan, MD (Panelist)


(50-minutes) Series of presentations followed by an expert panel discussion on the future of health care, leadership, and innovation in academic and clinical urology.



Objectives:

Educational purpose:
Prepare participants to build and lead high-performing clinical teams, drive quality improvement initiatives, and advance academic and health system leadership.

Learner take aways: 

  • ·       Identify strategies for building and leading high-performing clinical teams.
  • ·       Describe leadership approaches that promote quality improvement and patient safety.
  • ·       Recognize emerging trends that are shaping the future of health care delivery and academic medicine.
  • ·       Apply principles of change management to lead organizational and clinical transformation.
  • ·       Identify opportunities for urologists to influence health system strategy, policy, and innovation.
  • ·       Develop strategies for career advancement and leadership development in academic and clinical urology.
  • ·       Recognize effective approaches to mentoring, sponsorship, and talent development within a department.
  • ·       Describe best practices for fostering collaboration across multidisciplinary teams.
  • ·       Identify methods to align departmental priorities with institutional goals and value-based care initiatives.
  • ·       Discuss strategies for building resilient, adaptable clinical and academic programs.
The Research Enterprise and Global Influence
9:00AM - 10:20AM
Michael Leapman, MD (Presenter)
Janet Cowan, MA (Presenter)
June Chan, ScD (Presenter)
Robert Blelloch, MD, PhD
Sanoj Punnen, MD (Presenter)


(80-minutes) Series of presentations followed by an interactive Q&A discussion highlighting the UCSF Urology research enterprise and its global impact on the field. Faculty will examine the evolution of landmark research programs, transformative clinical discoveries, and influential publications that have shaped modern urologic practice. Topics include the history and impact of CaPSURE and the UCSF Urologic Oncology Database (UODB), seminal contributions to prostate cancer research, including diet and lifestyle studies, and the lasting influence of Dr. Peter Carroll's most impactful publications. Discussion will focus on how these innovations have advanced evidence-based clinical care, informed clinical guidelines, accelerated translational research, and fostered leadership and academic excellence in urology.



Objectives:

Educational purpose:
Provide participants with an understanding of how landmark clinical, translational, and health services research has shaped modern urologic practice, influenced clinical guidelines, and advanced evidence-based patient care. The session will also highlight the role of academic leadership, innovation, and research infrastructure in driving improvements in urology and preparing future leaders in the field.

Learner take aways: 

  • ·       Describe how landmark clinical, translational, and health services research has shaped modern urologic practice.
  • ·       Recognize the impact of major UCSF research initiatives, including CaPSURE and the UCSF Urologic Oncology Database (UODB), on evidence-based clinical care and research.
  • ·       Discuss how influential discoveries in prostate cancer research, including diet and lifestyle studies, have informed clinical guidelines and patient management.
  • ·       Identify strategies for translating research findings into clinical practice to improve patient outcomes.
  • ·       Recognize the role of academic leadership, collaboration, and innovation in advancing the field of urology and supporting career development.

Basic Science Matters
10:40AM - 11:45AM
Lisa Chesner, PhD (Moderator)
Peter Bruno, PhD (Presenter)
Robert Blelloch, MD, PhD (Presenter)
Davide Ruggero, PhD (Panelist)
David Quigley, PhD (Panelist)
Nadia Roan, PhD (Panelist)


(60-minutes) Series of presentations followed by an expert panel discussion focused on emerging basic science approaches to prostate cancer immunotherapies. Researchers will present two innovative prostate cancer vaccine strategies, highlighting the underlying scientific rationale, mechanisms of action, preclinical and early clinical evidence, and potential implications for future patient care. The expert panel will discuss the challenges and opportunities of translating basic science discoveries into clinical practice and the future role of cancer vaccines in the treatment of prostate cancer.



Objectives:

Educational purpose:
Enhance participants' understanding of emerging basic science discoveries in prostate cancer immunotherapies and their potential to inform future therapeutic strategies, clinical research, and patient care.

Learner take aways:
 

  • ·       Describe the scientific rationale and mechanisms underlying emerging prostate cancer vaccine approaches.
  • ·       Compare novel prostate cancer vaccine strategies and evaluate their potential role in future treatment paradigms.
  • ·       Interpret preclinical and early clinical evidence supporting the development of prostate cancer immunotherapies.
  • ·       Recognize the challenges and opportunities in translating basic science discoveries into clinical research and patient care.
  • ·       Discuss the potential impact of emerging immunotherapy approaches on the future management of prostate cancer.
A Conversation with Peter Carroll (Interview by Lindsay Hampson)
12:25PM - 12:45PM


Interview with Dr. Peter Carroll by Dr. Lindsay Hampson 
Innovation in Localized Prostate Cancer, Rapid-Fire Presentations
12:45PM - 1:45PM
Claire de la Calle, MD (Presenter)
Chien-Kuang C Ding, MD, PhD (Presenter)
Samuel L Washington, MD (Presenter)
Hao Nguyen, MD, PhD, Professor (Presenter)
Carissa Chu, MD (Presenter)


(60-minutes) Series of 8-minute presentations followed by an interactive Q&A discussion highlighting emerging innovations that are transforming prostate cancer detection, risk stratification, and treatment. Faculty will present the latest advances in active surveillance, the CANARY study, established and emerging biomarkers, and the impact of artificial intelligence and digital imaging on prostate cancer diagnosis and management. Additional presentations will explore interventions to improve access to prostate cancer screening and treatment, the future of intraoperative cancer imaging to enhance surgical precision, and the rationale, design, and early experience with neoadjuvant clinical trials for patients with high-risk prostate cancer. The discussion will focus on how these advances are shaping evidence-based practice, improving patient outcomes, and informing the future of prostate cancer care.



Objectives:

Educational purpose:
Provide participants with an evidence-based review of emerging advances in prostate cancer detection, risk stratification, imaging, and treatment. Through presentations on active surveillance, biomarkers, artificial intelligence, intraoperative imaging, strategies to improve equitable access to care, and neoadjuvant clinical trials, this session is designed to enhance participants' ability to evaluate and integrate new clinical and translational research into patient care. The program will also examine how these innovations are shaping future clinical practice and improving outcomes for patients with prostate cancer.

Learner take aways: 

  • ·       Evaluate emerging approaches to prostate cancer detection, risk stratification, and active surveillance using current clinical evidence.
  • ·       Compare established and novel biomarkers and their role in guiding prostate cancer diagnosis, prognosis, and treatment decisions.
  • ·       Describe the impact of artificial intelligence, digital pathology, and advanced imaging technologies on prostate cancer diagnosis and surgical care.
  • ·       Discuss strategies to improve equitable access to prostate cancer screening, diagnosis, and treatment.
  • ·       Interpret current evidence supporting neoadjuvant clinical trials and emerging treatment approaches for patients with high-risk prostate cancer.
  • ·       Recognize how innovations in clinical, translational, and surgical research are shaping the future of evidence-based prostate cancer care.
Redefining Clinical Excellence, Training, and Mentorship
1:45PM - 2:45PM
Maxwell Meng, MD (Moderator)
Anobel Odisho, MD (Presenter)
Sima Porten, MD (Presenter)
Tracy Downs (Presenter)
Matthew Cooperberg, MD (Presenter)
Viraj Master, MD, PhD, FACS (Presenter)


(60-minutes) Series of presentations followed by an interactive Q&A discussion exploring how innovation, leadership, and mentorship are redefining clinical excellence in urology. Faculty will present strategies for building high-performing clinical programs, advancing quality improvement initiatives, and applying lessons learned from innovation across health systems and other disease areas. Additional presentations will examine the future of informatics and artificial intelligence, the role of NEXUS and data integration in advancing research and patient care, national and global leadership in urologic oncology, and approaches to mentorship and workforce development. The discussion will focus on preparing the next generation of urologists to lead innovation, improve care delivery, and shape the future of academic and clinical practice.



Objectives:

Educational purpose:
Provide participants with practical strategies to advance clinical excellence through innovation, quality improvement, informatics, leadership, and mentorship. This session is designed to enhance participants' ability to build high-performing clinical programs, leverage data and emerging technologies to improve care delivery, and develop the leadership and mentoring skills needed to strengthen the urology workforce and shape the future of academic and clinical practice.

Learner take aways: 

  • ·       Identify strategies for building and sustaining high-performing clinical programs through innovation, quality improvement, and interdisciplinary collaboration.
  • ·       Describe how informatics, artificial intelligence, and data integration can be leveraged to improve clinical decision-making, research, and patient care.
  • ·       Apply principles of quality improvement and health system innovation to optimize care delivery and clinical outcomes.
  • ·       Recognize the role of leadership and mentorship in advancing academic medicine, fostering workforce development, and preparing the next generation of urologists.
  • ·       Discuss opportunities to lead organizational change and contribute to national and global initiatives that advance the field of urologic oncology.
  • ·       Evaluate emerging approaches to integrating clinical, translational, and health services research into evidence-based urologic practice.
Closing Remarks and Reflections by Peter Carroll
2:45PM - 3:00PM

 

University of California San Francisco Logo


University of California San Francisco 
Office of Continuing Medical Education
490 Illinois Street, Floor 7, San Francisco, CA 94143

Contact Us

©2025   Privacy Policy | Disclosure